MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from related
party loans
$9,744,230
something is missing
$8,617,553
Business combination
$26,000
Net cash (used in)
provided by financing...
$10,785,783
Canceled cashflow
$7,602,000
Net change in cash
and cash...
$89,742
Canceled cashflow
$10,696,041
Payments of deferred
offering costs
$7,602,000
Stock-based compensation
$140,403,000
Other assets
-$9,851,000
Accrued expenses
$1,231,000
Accounts payable
$521,000
Prepaid expenses
-$4,018
something is missing
-$8,617,553
Net cash used in
operating activities
-$2,078,488
Canceled cashflow
$152,010,018
Net loss
-$153,678,275
something is missing
-$410,231
Back
Back
Cash Flow
Semnur Pharmaceuticals, Inc. (DNQAF)
Semnur Pharmaceuticals, Inc. (DNQAF)
source: myfinsight.com